These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 4576632)

  • 21. The role of mescaline and D-lysergic acid in psychiatric treatment.
    Malitz S
    Dis Nerv Syst; 1966 Jul; 7 Suppl(7):39-42. PubMed ID: 5965283
    [No Abstract]   [Full Text] [Related]  

  • 22. The psychedelic experience--a new concept in psychotherapy.
    SHERWOOD JN; STOLAROFF MJ; HARMAN WW
    J Neuropsychiatr; 1962; 4():69-80. PubMed ID: 13977209
    [No Abstract]   [Full Text] [Related]  

  • 23. [Note apropos of the diagnostic and therapeutic use of hallucinogenic drugs (mescaline, L.S.D.25)].
    LANTER R; WEIL J; ROTH M
    Ann Med Psychol (Paris); 1962 Jul; 120(2)():244-53. PubMed ID: 13928711
    [No Abstract]   [Full Text] [Related]  

  • 24. CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS.
    HOLLISTER LE; SJOBERG BM
    Compr Psychiatry; 1964 Jun; 5():170-8. PubMed ID: 14156873
    [No Abstract]   [Full Text] [Related]  

  • 25. Persistent afterimages (palinopsia) and photophobia in a patient with a history of LSD use.
    Sunness JS
    Retina; 2004 Oct; 24(5):805. PubMed ID: 15492641
    [No Abstract]   [Full Text] [Related]  

  • 26. Albert Hofmann, the father of LSD (1906-2008).
    Fusar-Poli P; Borgwardt S
    Neuropsychobiology; 2008; 58(1):53-4. PubMed ID: 18799895
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of alcoholism with lysergide. Comment on the article by Smart et al., with special reference to issues of responsibility in research reporting.
    MacLean JR; Wilby WE
    Q J Stud Alcohol; 1967 Mar; 28(1):140-6. PubMed ID: 5339891
    [No Abstract]   [Full Text] [Related]  

  • 28. [FUNDAMENTALS OF A CONDITIONAL-GENETIC PSYCHOPATHOLOGY AS EXEMPLIFIED BY EXPERIMENTAL PSYCHOSIS].
    LEUNER H
    Nervenarzt; 1963 May; 34():198-206. PubMed ID: 14157764
    [No Abstract]   [Full Text] [Related]  

  • 29. Risperidone-associated, benign transient visual disturbances in schizophrenic patients with a past history of LSD abuse.
    Lerner AG; Shufman E; Kodesh A; Rudinski D; Kretzmer G; Sigal M
    Isr J Psychiatry Relat Sci; 2002; 39(1):57-60. PubMed ID: 12013711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mescaline and lysergic acid diethylamide: therapeutic implications of the drug-induced state.
    Denber HC
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:23-7. PubMed ID: 5775311
    [No Abstract]   [Full Text] [Related]  

  • 31. Clonidine treatment for hallucinogen persisting perception disorder.
    Lerner AG; Finkel B; Oyffe I; Merenzon I; Sigal M
    Am J Psychiatry; 1998 Oct; 155(10):1460. PubMed ID: 9766785
    [No Abstract]   [Full Text] [Related]  

  • 32. History and pharmacology of psychedelic drugs.
    Taylor WJ
    Int Z Klin Pharmakol Ther Toxikol; 1971 Aug; 5(1):51-7. PubMed ID: 4936558
    [No Abstract]   [Full Text] [Related]  

  • 33. The experimental use of psychedelic (LSD) psychotherapy.
    Pahnke WN; Kurland AA; Unger S; Savage C; Grof S
    Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):446-54. PubMed ID: 5566727
    [No Abstract]   [Full Text] [Related]  

  • 34. A role for psychedelics in psychiatry?
    Sandison R
    Br J Psychiatry; 2005 Nov; 187():483; author reply 484-5. PubMed ID: 16260828
    [No Abstract]   [Full Text] [Related]  

  • 35. Psychedelic drugs.
    Kieffer SN; Mortiz TB
    Pa Med; 1968 Apr; 71(4):57-67. PubMed ID: 4870533
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychedelic drugs.
    Kieffer SN; Moritz TB
    Pa Med; 1968 Apr; 71(4):57-67. PubMed ID: 4869313
    [No Abstract]   [Full Text] [Related]  

  • 37. [Synesthesias in the context of hallucinogen-induced persistent perception disorder following the use of lsd].
    Neven A; Blom JD
    Tijdschr Psychiatr; 2014; 56(11):748-52. PubMed ID: 25401683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The use of LSD in the psychotherapy of alcoholism].
    Taus L; Stehlík J
    Cesk Psychiatr; 1967 Apr; 63(2):121-7. PubMed ID: 6046890
    [No Abstract]   [Full Text] [Related]  

  • 39. Hallucinogenic drugs in psychiatric research and treatment. Perspectives and prospects.
    Strassman RJ
    J Nerv Ment Dis; 1995 Mar; 183(3):127-38. PubMed ID: 7891058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Turn on and tune in to evidence-based psychedelic research.
    Sessa B
    Lancet Psychiatry; 2015 Jan; 2(1):10-2. PubMed ID: 26359597
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.